Skip to Main Content

Paper Details

Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
Front Immunol
1
2023
COVID-19, COVID-19 mRNA, IFN, Patients, PsA, SARS-CoV, SARS-CoV-2 spike-specific neutralizing, SLE, anti-dsDNA, autoimmune diseases, double negative 2 (DN2) B cells, mRNA, patients, psoriatic arthritis, rheumatic, rheumatic disease, systemic lupus erythematosus, type I interferon, type I interferon (IFN) signature genes
Author NameAffiliation
Yongjin LiMayo Clinic
Yongjin LiMayo Clinic
Cynthia S CrowsonMayo Clinic
Cynthia S CrowsonMayo Clinic
  • 1 - 4

Datasets

Release 1.2